πŸ‡ΊπŸ‡Έ FDA
Patent

US 8304526

Antitumor effect of mutant Bik

granted A61KA61K38/1709A61P

Quick answer

US patent 8304526 (Antitumor effect of mutant Bik) held by The Board of Regents of the University of Texas System expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/1709, A61P, A61P31/00, A61P35/00